Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
508 Leser
Artikel bewerten:
(1)

Ascend Plastic Surgery Partners Announces the Acquisition of Ponte Vedra Plastic Surgery, Setting a New Standard for Excellence in Aesthetic Medicine

PONTE VEDRA BEACH, FL / ACCESSWIRE / April 9, 2024 / Ascend Plastic Surgery Partners is pleased to announce its latest partnership with Ponte Vedra Plastic Surgery (PVPS), a renowned institution in the field of plastic and cosmetic surgery. This partnership advances Ascend's mission to elevate patient care standards and provide exemplary aesthetic services across the United States. PVPS expands Ascend's presence into Florida, adding a fifth state, six additional surgeons, and six new locations to the Ascend footprint.

Ponte Vedra Plastic Surgery

Ponte Vedra Plastic Surgery
2024 Logo



Since its founding 30 years ago, PVPS has built a legacy of excellence, innovation, and compassionate care. Founding partners Dr. Cayce Rumsey and Dr. Robert Burk, partnered with Dr. Erez Sternberg, Dr. Hollie Hickman, and CEO, Dennis Oistacher to cultivate an exemplary operation focused on advancing aesthetic medicine and embodying a culture of excellence. "Joining forces with Ascend Plastic Surgery Partners represents a pivotal chapter in our journey," said Dennis Oistacher. "It's a partnership that reflects our shared commitment to unparalleled patient care, innovation, and the continuation of the legacy we've built at PVPS."

Ascend, under the leadership of Chief Medical Officer Dr. William Hedden and CEO Anthony Milonas, is recognized for its commitment to clinical excellence and personalized patient experiences. "The integration of PVPS into the Ascend family marks a momentous step forward in our quest to set a new standard of excellence in the aesthetic medicine industry," Anthony Milonas remarked. "We are honored to carry forward the incredible legacy of PVPS, a testament to the vision of its founders and the dedication of its team."

"We are excited for the next phase of PVPS's growth and are thrilled to partner with the Ascend team. We are looking forward to sharing in best practices while continuing to optimize patient care and results, as we look to expand," stated Dr. Robert Burk, partner physician at PVPS.

As Ascend Plastic Surgery Partners welcomes PVPS into its fold, the focus remains on preserving the strong company culture and positive attributes that have defined PVPS. This merger not only signifies a blending of talents and resources but also a shared vision for the future of aesthetic medicine - a future where patient well-being and clinical excellence lead the way.

PVPS was advised by Westcove Partners and Advos Legal. Ascend was advised by McDermott Will & Emery and Berkley Research Group.

About Ponte Vedra Plastic Surgery: Ponte Vedra Plastic Surgery is a premier plastic surgery practice serving patients in North Florida and South Georgia, known for its innovative techniques, compassionate care, and highly skilled team of professionals. Founded by Dr. Cayce Rumsey and Dr. Robert Burk, PVPS is dedicated to enhancing patient lives through aesthetic medicine. For more information, visit www.pvps.com.

About Ascend Plastic Surgery Partners: Headquartered in Atlanta, Georgia, Ascend Plastic Surgery Partners is at the forefront of the aesthetic medicine industry, committed to providing exceptional patient care and advancing the field through innovation and expertise. Led by CEO Anthony Milonas and Chief Medical Officer Dr. William Hedden, Ascend is dedicated to elevating the standard of care in plastic and cosmetic surgery. For more information, visit www.ascendpsp.com.

For Media inquiries contact: Lori Moonen, Lori@CreativeSparkJax.com

Contact Information

Lori Moonen
Marketing Agency
lori@creativesparkjax.com
9042287318

Related Files

Ascend Plastic Surgery Partners Announces the Acquisition of Ponte Vedra Plastic Surgery 4.5.2024

Related Images

Ponte Vedra Plastic Surgery

Ponte Vedra Plastic Surgery
2024 Logo

Ascend Original Logo

Ascend Original Logo
Ascend Logo

SOURCE: Ponte Vedra Plastic Surgery

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.